Huisheng Biotech (300871.SZ) disclosed plans to issue A-shares to specific targets in 2024. This issuance...
According to the Zhitong Finance App, Huisheng Biotech (300871.SZ) disclosed plans to issue A-shares to specific targets in 2024. The target of this issuance is Chu Sheng (Hubei) Investment Partnership (Limited Partnership) (“Chu Sheng Investment”), which is an enterprise controlled by the company's actual controllers Zhang Weiyuan and Yu Jiao'e. The number of shares issued this time is no more than 26.123,300 shares (inclusive), and the issue price is 9.57 yuan/share. The total amount of capital to be raised in this offering will not exceed RMB 250 million (inclusive). After deducting the issuance fee, all will be used to supplement working capital.